Austco Healthcare Ltd · ASX:AHC
Austco Healthcare — Investor Presentation (March 2022)
24 slides from Austco Healthcare's investor presentation, Mar 18, 2022
Slide 1: Roadshow Presentation March 2022
ROADSHOW PRESENTATION MARCH 2022 Clayton Astles Chief Executive Officer Brendan Maher Chief Finance Officer
Slide 2: Products
2 Austco Healthcare PRODUCTS Austco has continued to innovate, with a surplus of new features ready to hit the market
Slide 3: Built-in RTLS
3 Austco Healthcare BUILT-IN RTLS Uses existing nurse call infrastructure for a cost-effective solution Data and events drive automated processes Robust reporting meets facility requirements and regulatory standards Multiple contracts won on the strength of this feature. Real-time location has becom
Slide 4: Compact Master Station
4 Austco Healthcare COMPACT MASTER STATION Component shortage has affected our older stations Replacement is Android-based device Manages alarms Communications hub Workflow capable Standardising on Android means less work, easier maintenance
Slide 5: LCD Annunciator
5 Austco Healthcare LCD ANNUNCIATOR Displays non-western characters Customisable messages Single or double sided Right-to-left languages Customer branding Uses Austco’s new micro services architecture
Slide 6: Make It Your Own
6 Austco Healthcare MAKE IT YOUR OWN New devices feature: Customer branding Multi-language support Right to left language support Austco’s API for communications Customisable devices are at home in any environment
Slide 7: Clinical Care and Communications
7 Austco Healthcare CLINICAL CARE AND COMMUNICATIONS CC&C apps are mobile nurse call systems The next “big thing” for communications technology Apps typically include: Alarm and alert notification EMR/clinical system integration Voice and text Workflow Differentiators: Scanning PIDs and medications
Slide 8: Pulse Software Platform
8 Austco Healthcare PULSE CARE PULSE MOBILE Alarm and alert management Clinical care & communication Workflow Communications PULSE PULSE REPORTS PULSE MANAGE SOFTWARE Enterprise reporting “Productised” API Management application PLATFORM PULSE ATTEND* PULSE ENGAGE* Remote patient monitoring Patient
Slide 9: Real-Time Health
9 Austco Healthcare Nurse Call EMR / EHR REAL-TIME RTLS ADT HEALTH Medical Devices Bed Flow Data from all systems shared Any system which may exchange data about a patient or their care Patient Engagement Care Communications Initially for reporting, eventually for machine learning and automated care
Slide 10: Supply Chain Challenges
SUPPLY CHAIN CHALLENGES Supply chain challenges remain and are expected to remain for FY22 and possibly beyond: • To mitigate the risks of supply chain interruptions we have invested in additional inventory • Increases in raw material costs and additional freight costs will continue to test margins,
Slide 11: Sales & Marketing
11 Austco Healthcare SALES & MARKETING Customers are asking for • More integrated, feature-rich systems • Advanced IT deployments and system readiness • Vendors who share their vision Austco excels at all of these MESSAGE SALES TEAM STRATEGY Nurse call isn’t buttons and Ensure everyone representing
Slide 12: Strategic Objectives
12 Austco Healthcare STRATEGIC OBJECTIVES
Slide 13: Revenue Strategies
13 Austco Healthcare FY22 STRATEGIC PLAN REVENUE STRATEGIES 01 02 03 Drive organic revenue growth Growth by acquisition Increase software and SMA revenue Recruit more sales professionals, focus on Target feature rich and software capable resellers Recruit software focused channel partners USA, UK, A
Slide 14: Operational Strategies
14 Austco Healthcare FY22 STRATEGIC PLAN OPERATIONAL STRATEGIES 01 02 03 Improve margins Build brand awareness in Continue to innovate growth markets Transition global distribution from Hong Establish strategic partnerships with market Enhance Built-in RTLS with new functionality Kong to Malaysia le
Slide 15: Outlook
OUTLOOK Modern and extensible operating platform Market-leading products through sustained R&D commitment Increased Investment in Sales and Marketing Uncertainty still exists for the business, which will need to be managed throughout FY22, and possibly beyond Robust order book at $23.3m Austco Healt
Slide 16: Financial Performance
16 Austco Healthcare FINANCIAL PERFORMANCE
Slide 17: 1HFY22 Financial Snapshot
17 Austco Healthcare REVENUE SOFTWARE AND SMA REVENUE $16.0M 15.3% Of revenue $2.1M or 15% on pcp 1.7% points on pcp MARGIN EBIT 1HFY22 FINANCIAL 52.9% $1.8M SNAPSHOT 1.5% points on pcp $0.7M or 65% on pcp NPAT CASH $1.5M $7.1M $0.7M or 83% on pcp $0.7M since June 2021
Slide 18: Revenue from Customers
18 Austco Healthcare 18 REVENUE FROM CUSTOMERS Revenue from customers increased by 15% to $16.0m for the half year compared to the prior comparative period (pcp) due to slightly improved 17,345 access restrictions to hospitals and aged care facilities. The impact of site 16,778 access restrictions r
Slide 19: Open Sales Orders
19 Austco Healthcare 19 30 OPEN SALES ORDERS 15 Open Sales Orders represent confirmed contracted orders from customers 24.5 that have not yet been fulfilled. 22.9 23.3 • Since the beginning of COVID-19 we have observed a material build up in 20.1 our confirmed orders as site access restrictions and
Slide 20: Gross Profit and Margin
20 Austco Healthcare 20 GROSS PROFIT AND MARGIN 51.4% 52.7% 51.4% 55.2% 52.9% Gross margin % in 1HFY22 was 52.9%, which was slightly up on the pcp but down from 2HFY21. Contributing to this were: • Supply chain cost increases from increased raw materials and higher freight costs have maintained down
Slide 21: Earnings
21 Austco Healthcare 21 REPORTED NPAT EARNINGS Reported NPAT is $1.5m for 1HFY22 compared to $0.8m for 1HFY21. 2,597 The second half NPAT of $2.6 million drove the full-year result as we benefited from a rebound in revenues, particularly in the last quarter. 1,695 1,511 Included in the profit for th
Slide 22: Cash & Debt
22 Austco Healthcare 22 CASH & DEBT Debt Cash Cash on hand remains strong at $7.1m The December 2019 capital raising proceeds have now started to be deployed. We have invested in strategic inventory and put on a number of new sales resources in North America and the Middle East to pursue our organic
Slide 23: Disclaimer
23 Austco Healthcare DISCLAIMER This presentation was prepared by Austco Healthcare Limited and was authorised for respective affiliates, associates, shareholders, directors, officers, employees, agents, release by the Board of the Company. representatives and advisers (the Austco Parties) make any
Slide 24: Thank You
24 Austco Healthcare THANK Clayton Astles CEO & Executive Director Aust: +61 411 531 170 YOU US: +1 416 565 7457 clayton.astles@austco.com Brendan Maher CFO & Company Secretary Aust: +61 439 369 551 brendan.maher@austco.com
Austco Healthcare — Investor Presentation (March 2022) on 6ix